Emerging role of Janus kinase inhibitors for the treatment of atopic dermatitis
用户qgRSP4os3S6M
10天前
36
10
已完结
1. 系统已在2025-10-01 12:17:39对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
R Singh, CE Heron, RI Ghamrawi…
ImmunoTargets and …, 2020
Taylor & Francis
… Ruxolitinib is a selective JAK1 and high potency JAK2 inhibitor … Low rates of skin infections may occur in individuals using … an emerging target for topical treatment of inflammatory skin …
